{"id":"https://openalex.org/W4415648564","doi":"https://doi.org/10.1021/acs.bioconjchem.5c00424","title":"Identification of a Novel Linker Enabling the Bioconjugation of a Cyclic Dinucleotide for the STING Antibody-Drug Conjugate TAK-500","display_name":"Identification of a Novel Linker Enabling the Bioconjugation of a Cyclic Dinucleotide for the STING Antibody-Drug Conjugate TAK-500","publication_year":2025,"publication_date":"2025-10-27","ids":{"openalex":"https://openalex.org/W4415648564","doi":"https://doi.org/10.1021/acs.bioconjchem.5c00424","pmid":"https://pubmed.ncbi.nlm.nih.gov/41143331"},"language":"en","primary_location":{"id":"doi:10.1021/acs.bioconjchem.5c00424","doi":"https://doi.org/10.1021/acs.bioconjchem.5c00424","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.bioconjchem.5c00424","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.5c00424?ref=article_openPDF","source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.5c00424?ref=article_openPDF","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092122951","display_name":"Hong Myung Lee","orcid":"https://orcid.org/0009-0002-0728-7852","observed_orcids":["https://orcid.org/0009-0002-0728-7852"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hong Myung Lee","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":"https://orcid.org/0009-0002-0728-7852","affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059060833","display_name":"Kojo Abdul-Hadi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kojo Abdul-Hadi","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061743196","display_name":"Vicky A. Appleman","orcid":"https://orcid.org/0000-0002-9132-1322","observed_orcids":["https://orcid.org/0000-0002-9132-1322"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Vicky A. Appleman","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102468544","display_name":"David Cardin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"David Cardin","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079559162","display_name":"Linlin Dong","orcid":"https://orcid.org/0000-0002-7944-8582","observed_orcids":["https://orcid.org/0000-0002-7944-8582"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Linlin Dong","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":"https://orcid.org/0000-0002-7944-8582","affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088847395","display_name":"Dylan B. England","orcid":"https://orcid.org/0000-0002-2550-0963","observed_orcids":["https://orcid.org/0000-0002-2550-0963"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Dylan England","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002455054","display_name":"Michelle L. Ganno","orcid":"https://orcid.org/0009-0001-3322-0670","observed_orcids":["https://orcid.org/0009-0001-3322-0670"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michelle L. Ganno","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091206350","display_name":"Rachel E. Gershman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rachel Gershman","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013556769","display_name":"Kenneth M. Gigstad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenneth Gigstad","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042576856","display_name":"Nanda K. Gulavita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nanda Gulavita","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067033625","display_name":"Zhigen Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Zhigen Hu","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004765184","display_name":"Jian Huang","orcid":"https://orcid.org/0000-0002-5180-9833","observed_orcids":["https://orcid.org/0000-0002-5180-9833"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jian Huang","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073180534","display_name":"Shih\u2010Chung Huang","orcid":"https://orcid.org/0000-0001-8510-4850","observed_orcids":["https://orcid.org/0000-0001-8510-4850"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shih-Chung Huang","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047315861","display_name":"David P. P. Lok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"David Lok","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085898289","display_name":"Li\u2010Ting Ma","orcid":"https://orcid.org/0000-0001-6028-0831","observed_orcids":["https://orcid.org/0000-0001-6028-0831"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Liting Ma","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013040004","display_name":"Jenna Malley","orcid":"https://orcid.org/0000-0001-9862-5452","observed_orcids":["https://orcid.org/0000-0001-9862-5452"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jenna Malley","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109208794","display_name":"Miho Mizutani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Miho Mizutani","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001038093","display_name":"Nina Molchanova","orcid":"https://orcid.org/0009-0007-8133-6962","observed_orcids":["https://orcid.org/0009-0007-8133-6962"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nina Molchanova","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106245056","display_name":"Konstantin I. Piatkov","orcid":"https://orcid.org/0009-0004-9337-6329","observed_orcids":["https://orcid.org/0009-0004-9337-6329"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Konstantin I. Piatkov","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Elise Rice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Elise Rice","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084646796","display_name":"Zhan Wan Shi","orcid":"https://orcid.org/0000-0003-4464-3086","observed_orcids":["https://orcid.org/0000-0003-4464-3086"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Zhan Shi","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046270168","display_name":"\u0160t\u011bp\u00e1n Vysko\u010dil","orcid":"https://orcid.org/0000-0001-8178-7113","observed_orcids":["https://orcid.org/0000-0001-8178-7113"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Stepan Vyskocil","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":"https://orcid.org/0000-0001-8178-7113","affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079109793","display_name":"Jianing Wang","orcid":"https://orcid.org/0009-0003-4168-7873","observed_orcids":["https://orcid.org/0009-0003-4168-7873"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jianing Wang","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"He Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"He Xu","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073966216","display_name":"Tianlin Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tianlin Xu","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108549063","display_name":"Dong Mei Zhang","orcid":"https://orcid.org/0009-0006-5718-5503","observed_orcids":["https://orcid.org/0009-0006-5718-5503"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Dong Mei Zhang","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100329258","display_name":"Ji Zhang","orcid":"https://orcid.org/0000-0002-1135-7713","observed_orcids":["https://orcid.org/0000-0002-1135-7713"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ji Zhang","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055806462","display_name":"Adnan O. Abu\u2010Yousif","orcid":"https://orcid.org/0000-0002-7670-0041","observed_orcids":["https://orcid.org/0000-0002-7670-0041"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Adnan O. Abu-Yousif","raw_affiliation_strings":["Takeda Pharmaceuticals International Company","Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Pharmaceuticals International Company","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Pharmaceuticals International Company, Cambridge, Massachusetts 02139, United States","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5092122951"],"corresponding_institution_ids":["https://openalex.org/I44892455"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":1.6346,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.83918209,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"36","issue":"11","first_page":"2423","last_page":"2435"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.21369999647140503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.21369999647140503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.13120000064373016,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.06430000066757202,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sting-agonist","display_name":"STING agonist","score":0.7630000114440918},{"id":"https://openalex.org/keywords/cyclic-dinucleotides","display_name":"cyclic dinucleotides","score":0.8190000057220459},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9900000095367432},{"id":"https://openalex.org/keywords/self-immolative-linker","display_name":"self-immolative linker","score":0.7960000038146973},{"id":"https://openalex.org/keywords/cathepsin-b-cleavable-linker","display_name":"cathepsin B cleavable linker","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cysteine-conjugation","display_name":"cysteine conjugation","score":0.8379999995231628},{"id":"https://openalex.org/keywords/plasma-stability","display_name":"plasma stability","score":0.6449999809265137},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7139999866485596},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.6209999918937683},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8870000243186951}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9200999736785889},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.9154000282287598},{"id":"https://openalex.org/C2779300339","wikidata":"https://www.wikidata.org/wiki/Q7617409","display_name":"Sting","level":2,"score":0.7397000193595886},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.7105000019073486},{"id":"https://openalex.org/C23963754","wikidata":"https://www.wikidata.org/wiki/Q4914729","display_name":"Bioconjugation","level":2,"score":0.6837000250816345},{"id":"https://openalex.org/C2779201268","wikidata":"https://www.wikidata.org/wiki/Q186474","display_name":"Cysteine","level":3,"score":0.5311999917030334},{"id":"https://openalex.org/C2777349159","wikidata":"https://www.wikidata.org/wiki/Q18055374","display_name":"Stimulator of interferon genes","level":4,"score":0.43290001153945923},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.42309999465942383},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4108000099658966},{"id":"https://openalex.org/C2779138802","wikidata":"https://www.wikidata.org/wiki/Q418602","display_name":"Dipeptide","level":3,"score":0.36579999327659607},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35269999504089355},{"id":"https://openalex.org/C2776444769","wikidata":"https://www.wikidata.org/wiki/Q259464","display_name":"Muramyl dipeptide","level":3,"score":0.3463999927043915},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3443000018596649},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.3334999978542328},{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.3158000111579895},{"id":"https://openalex.org/C2776281265","wikidata":"https://www.wikidata.org/wiki/Q420327","display_name":"Hydroxamic acid","level":2,"score":0.29919999837875366},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.29649999737739563},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.2856000065803528},{"id":"https://openalex.org/C186852380","wikidata":"https://www.wikidata.org/wiki/Q1142521","display_name":"Electroporation","level":3,"score":0.2802000045776367},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.26600000262260437},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.2590999901294708},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.25769999623298645}],"mesh":[{"descriptor_ui":"D000099197","descriptor_name":"STING Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000099197","descriptor_name":"STING Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/acs.bioconjchem.5c00424","doi":"https://doi.org/10.1021/acs.bioconjchem.5c00424","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.bioconjchem.5c00424","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.5c00424?ref=article_openPDF","source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},{"id":"pmid:41143331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41143331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:11443195","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12635970","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1021/acs.bioconjchem.5c00424","doi":"https://doi.org/10.1021/acs.bioconjchem.5c00424","is_oa":true,"landing_page_url":"https://doi.org/10.1021/acs.bioconjchem.5c00424","pdf_url":"https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.5c00424?ref=article_openPDF","source":{"id":"https://openalex.org/S155115410","display_name":"Bioconjugate Chemistry","issn_l":"1043-1802","issn":["1043-1802","1520-4812"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioconjugate Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8999999761581421}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4415648564.pdf","grobid_xml":"https://content.openalex.org/works/W4415648564.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1524815067","https://openalex.org/W1977241343","https://openalex.org/W1993860509","https://openalex.org/W1994350776","https://openalex.org/W2010363872","https://openalex.org/W2046185660","https://openalex.org/W2052768531","https://openalex.org/W2053800409","https://openalex.org/W2089010103","https://openalex.org/W2090057677","https://openalex.org/W2138326965","https://openalex.org/W2138780833","https://openalex.org/W2171368669","https://openalex.org/W2281046076","https://openalex.org/W2288867196","https://openalex.org/W2323748784","https://openalex.org/W2337369926","https://openalex.org/W2551326875","https://openalex.org/W2607719113","https://openalex.org/W2790219752","https://openalex.org/W2802422145","https://openalex.org/W2891142726","https://openalex.org/W2907564726","https://openalex.org/W2995171541","https://openalex.org/W3003211156","https://openalex.org/W3111948793","https://openalex.org/W3160876221","https://openalex.org/W4281990314","https://openalex.org/W4309245499","https://openalex.org/W4324311110","https://openalex.org/W4385191576","https://openalex.org/W4392982984","https://openalex.org/W4400522799","https://openalex.org/W4401733701","https://openalex.org/W4407254112"],"related_works":[],"abstract_inverted_index":{"STING":[0,26,44,64],"activates":[1],"the":[2,34,38,43,57,61,80,85,102,115,146],"innate":[3],"immune":[4,30,48],"system":[5],"by":[6,40],"inducing":[7],"type-1":[8],"interferon":[9],"(IFN)":[10],"production":[11],"and":[12,84,123],"has":[13],"been":[14],"pursued":[15],"as":[16,143,145],"a":[17,92],"therapeutic":[18,35],"option":[19],"in":[20],"immuno-oncology.":[21],"The":[22,50,110],"targeted":[23,47,58],"delivery":[24,59],"of":[25,37,60,82,114,148],"agonists":[27,39],"to":[28,55,67],"CCR2+":[29,68],"cells":[31,69],"could":[32],"enhance":[33],"window":[36],"selectively":[41],"activating":[42],"pathway":[45],"within":[46],"cells.":[49],"chemistry":[51],"strategy":[52],"was":[53],"established":[54],"enable":[56],"cyclic":[62],"dinucleotide":[63],"agonist":[65],"dazostinag":[66,83,116],"through":[70],"an":[71],"antibody-drug":[72],"conjugate":[73],"(ADC)":[74],"approach.":[75],"A":[76],"self-immolative":[77],"spacer":[78],"between":[79],"adenine":[81],"Cathepsin-B":[86],"cleavable":[87],"Val-Ala":[88],"dipeptide":[89],"linker":[90,93],"rendered":[91],"payload":[94,104],"that":[95],"exhibits":[96],"strong":[97],"plasma":[98],"stability":[99],"while":[100],"allowing":[101],"rapid":[103],"release":[105],"upon":[106],"internalization":[107],"into":[108],"lysosomes.":[109],"stochastic":[111],"cysteine":[112],"conjugation":[113],"containing":[117],"these":[118],"linkers":[119],"provided":[120],"ADC":[121],"TAK-500":[122],"its":[124],"mouse":[125,135],"surrogate":[126],"mTAK-500":[127,137],"with":[128],"DAR":[129],"=":[130],"4.":[131],"In":[132],"syngeneic":[133],"tumor-bearing":[134],"models,":[136],"showed":[138],"target":[139],"specific":[140],"antitumor":[141],"activity":[142],"well":[144],"induction":[147],"immune-stimulating":[149],"cytokines.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-29T00:00:00"}